CDLR
Cadeler A/S
CDLR trails on the overall score without a compensating advantage in the available component scores.
RKLB
Rocket Lab USA, Inc.
RKLB has the edge over CDLR overall, supported by stronger fundamentals.
CDLR Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Under pressure | |
| Under pressure |
CDLR's revenue and profitability are currently healthy, but its cash flow and balance sheet are under pressure.
RKLB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
CDLR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 2.9x | $6.93 | — |
| Cheap | 6.2x | $14.63 | +111% |
| Fair | 7.2x | $17.08 | +146% |
| Expensive | 23x | $55.05 | +694% |
Historical ranges are pointers, not guarantees.
CDLR's PE is 2.9x, but its earnings don't support one, so it isn't a reliable read right now.
RKLB PE Valuation
RKLB has no meaningful PE right now: it lost money over the past year.
CDLR Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Strong growth | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect strong earnings and revenue growth for CDLR, but weaker profitability.
RKLB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
RKLB has the edge over CDLR on the outlook, with more favorable profitability expectations.
CDLR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $2.36 | -19% |
| Q1 2026 | $3.29 | +194% |
| Q4 2025 | $3.40 | +310% |
| Q3 2025 | $3.31 | +$3.35 |
| Q2 2025 | $2.90 | +$3.28 |
| Q1 2025 | $1.12 | +11100% |
| Q4 2024 | $0.83 | +159% |
| Q3 2024 | -$0.04 | -103% |
CDLR has the edge over RKLB on earnings quality, reporting a profit while its opponent remains loss making.
RKLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.36 | +$0.03 |
| Q2 2026 | -$0.27 | +$0.19 |
| Q1 2026 | -$0.32 | +$0.09 |
| Q4 2025 | -$0.37 | +$0.01 |
| Q3 2025 | -$0.39 | -$0.02 |
| Q2 2025 | -$0.46 | -$0.11 |
| Q1 2025 | -$0.41 | -$0.04 |
| Q4 2024 | -$0.38 | $0.00 |
RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.
CDLR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $319.4M | +23% |
| Q1 2026 | $138.6M | +90% |
| Q4 2025 | $184.4M | +93% |
| Q3 2025 | $171.4M | +91% |
| Q2 2025 | $258.9M | +269% |
| Q1 2025 | $72.7M | +243% |
| Q4 2024 | $95.5M | +393% |
| Q3 2024 | $89.5M | +244% |
CDLR has the edge over RKLB on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 40% | -30 points |
| Q1 2026 | 6.2% | -1.1 points |
| Q4 2025 | 39% | -4.5 points |
| Q3 2025 | 52% | +10 points |
| Q2 2025 | 70% | +40 points |
| Q1 2025 | 7.4% | +113 points |
| Q4 2024 | 44% | +134 points |
| Q3 2024 | 41% | +38 points |
CDLR has the edge over RKLB on profitability, with a higher operating margin.
RKLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.8M | +73% |
| Q2 2026 | $234.1M | +62% |
| Q1 2026 | $200.3M | +63% |
| Q4 2025 | $179.7M | +36% |
| Q3 2025 | $155.1M | +48% |
| Q2 2025 | $144.5M | +36% |
| Q1 2025 | $122.6M | +32% |
| Q4 2024 | $132.4M | +121% |
RKLB's revenue has grown year over year every quarter since late 2021: $268M last quarter, up 73% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -30% | +8.5 points |
| Q2 2026 | -25% | +17 points |
| Q1 2026 | -28% | +20 points |
| Q4 2025 | -28% | +11 points |
| Q3 2025 | -38% | +12 points |
| Q2 2025 | -41% | -0.5 points |
| Q1 2025 | -48% | -1.9 points |
| Q4 2024 | -39% | +41 points |
RKLB's operating margin was −30% last quarter, up 8.5 points from the same quarter a year ago.
CDLR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$25.6M | +$147M |
| Q1 2026 | -$54.4M | +$441.4M |
| Q4 2025 | -$239.1M | -$218.7M |
| Q3 2025 | -$49M | +$201.6M |
| Q2 2025 | -$172.6M | +$38.6M |
| Q1 2025 | -$495.8M | -$397.3M |
| Q4 2024 | -$20.4M | +$14.3M |
| Q3 2024 | -$250.7M | -1045% |
CDLR has the edge over RKLB on cash flow, with more consistent year-over-year improvement.
RKLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$23.9M | +$45.5M |
| Q2 2026 | -$110.1M | -$54.8M |
| Q1 2026 | -$77.4M | +$5.5M |
| Q4 2025 | -$114.2M | -$90.2M |
| Q3 2025 | -$69.4M | -$27.5M |
| Q2 2025 | -$55.3M | -$26.9M |
| Q1 2025 | -$82.9M | -$61.1M |
| Q4 2024 | -$23.9M | +$28.7M |
RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.
CDLR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 3.6x | Elevated |
| Q1 2026 | 3.0x | Moderate |
| Q4 2025 | 3.4x | Elevated |
| Q3 2025 | 3.2x | Elevated |
| Q2 2025 | 3.6x | Elevated |
| Q1 2025 | 6.0x | High |
| Q4 2024 | 4.1x | High |
| Q3 2024 | 7.1x | High |
CDLR's net debt is about 3.6 years of its operating earnings (EBITDA), about the same as a year ago.
RKLB Net Leverage
RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CDLR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 27.7 | Oversold |
| Stochastic | 33.9 | Neutral |
CDLR's weekly RSI is 28 (oversold) and its Stochastic is 34 (neutral).
RKLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 27.6 | Neutral |
RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).
CDLR PE vs Industrials Sector
| Metric | CDLR | Sector median | Relative |
|---|---|---|---|
| PE | 2.9x | 24x | 88% below |
| PE % | 1 | 49 | 48 pts below |
CDLR is trading at 2.9x earnings, a 88% discount to the Industrials sector's median of 24x, though its earnings don't support one.
RKLB PE vs Industrials Sector
RKLB has no meaningful PE right now: it lost money over the past year.
CDLR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $19.6 | 65% below |
| 20 week MA | $22.1 | 69% below |
| 50 week MA | $23.0 | 70% below |
| 100 week MA | $21.6 | 68% below |
RKLB has stronger trend alignment. CDLR is above 0 of 4 weekly averages versus RKLB above 3 of 5.
RKLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.4 | 4.3% above |
| 20 week MA | $68.1 | 5.9% below |
| 50 week MA | $77.6 | 17% below |
| 100 week MA | $56.5 | 13% above |
| 200 week MA | $31.4 | 104% above |
RKLB's trend is mixed: it's above three of its five weekly moving averages, and 104% above its 200-week average.
CDLR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $18.4 | $18.4 | 0% |
| 2024 | $18.4 | $22.5 | +22% |
| 2025 | $22.5 | $19.3 | -14% |
| 2026 YTD | $19.3 | $6.93 | -64% |
CDLR has finished lower in two of the last three years. It's down 64% so far in 2026.
RKLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.82 | $10.3 | +4.9% |
| 2021 | $10.3 | $12.0 | +17% |
| 2022 | $12.0 | $3.77 | -69% |
| 2023 | $3.77 | $5.53 | +47% |
| 2024 | $5.53 | $27.2 | +392% |
| 2025 | $27.2 | $70.7 | +160% |
| 2026 YTD | $70.7 | $64.1 | -9.3% |
RKLB has the edge over CDLR on returns for 2026, with the stronger performance.